Microfluidic Cell Barcoding and Sequencing Linkage

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current single-cell RNA-sequencing (scRNA-seq) methods lack the ability to link imaging and sequencing measurements, limiting the characterization of phenotypic traits such as morphological features, protein expression, and metabolic composition, which are not directly encoded in the genome.

Innovation Solution

A microfluidic device is used to capture and image single cells, followed by on-chip barcoding and sequencing, allowing for the correlation of gene expression with cellular morphology or phenotype through the use of preloaded barcoded reverse-transcription primers and efficient library preparation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If microdroplet- or microwell-based barcoding is used to increase throughput, then scalability is improved, but the ability to link imaging and sequencing measurements is lost

Engineering Contradiction:
ImprovethroughputVSAvoidlinking imaging and sequencing measurements
Core Design Contradiction:
ProductivityVSLoss of information

Solution Approach 1:

The patent combines imaging and sequencing operations within the same microfluidic device, merging two previously separate processes. Cells are imaged in microfluidic chambers, then the same cells undergo barcoding and sequencing in the same device, enabling linkage of phenotypic and transcriptomic data while maintaining high throughput

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent uses barcoded reverse-transcription primers as an intermediary to link imaging and sequencing measurements. These primers carry barcode sequences that serve as identifiers to connect the visual imaging data with the sequencing data from the same cells

Inventive Principle:
Principle #24Intermediary (Mediator)

2Loss of information

If C1 microfluidic platform is used for in-tube library preparation, then imaging and sequencing can be linked, but scalability is limited

Engineering Contradiction:
Improvelinking imaging and sequencing measurementsVSAvoidscalability
Core Design Contradiction:
Loss of informationVSProductivity

Solution Approach 1:

The patent segments the library preparation process into discrete microfluidic modules (lysis chamber, reverse-transcription chamber, amplification chamber) that can be independently optimized and scaled. This modular segmentation enables high-throughput processing while maintaining the ability to link imaging and sequencing data

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent replaces manual in-tube library preparation with automated microfluidic processing. Cells are automatically delivered to microfluidic chambers, reagents are precisely dispensed, and reactions are controlled through integrated valves and pumps, enabling scalability while maintaining data linkage capabilities

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Ease of operation

If standard microliter-scale plate-based protocols are used, then ease of operation is maintained, but throughput and cost efficiency are reduced

Engineering Contradiction:
Improveprotocol simplicityVSAvoidthroughput
Core Design Contradiction:
Ease of operationVSProductivity

Solution Approach 1:

The patent implements self-service through automated microfluidic processing where the device itself performs cell delivery, reagent dispensing, reaction control, and data linkage without requiring manual intervention. This automation maintains operational simplicity while dramatically increasing throughput

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables high-resolution imaging and sensitive scRNA-seq data acquisition from the same single cells, improving the detection of genes and reducing technical noise, thereby enhancing the understanding of cellular traits and gene expression profiles.

Implementation Method 1

capturing and imaging single cells

Methodology Applied
Scientific EffectOptical imaging: Photography

Implementation Method 2

reverse-transcription primers

Methodology Applied
Scientific EffectReverse transcription: Enzyme

Implementation Method 3

cellular barcodes and unique molecular identifiers (UMIs) are incorporated into cDNA by reverse transcription

Methodology Applied
Scientific EffectMolecular barcoding:

Implementation Method 4

determining the sequence of one or more transcribed genes from a single cell

Methodology Applied
Scientific EffectDNA sequencing:

Data Source

PatentUS20230093891A1Microfluidic cell barcoding and sequencing
Publication Date: 2023.03.30 CZ BIOHUB SF LLC
  • US20230093891A1 patent drawing
  • US20230093891A1 patent drawing
  • US20230093891A1 patent drawing

AI summary

The present disclosure provides materials and methods to link imaging and sequencing measurements of a single cell. Sequencing information can be linked with phenotypic measurements that are not directly encoded in the genome such as morphological features, protein expression & localization, organelle dynamics, or the metabolic composition of a cell.